CANNARA BIOTECH INC (LOVE.CA) Stock News

Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

Cannara Biotech will present at the Ventum Canadian Cannabis Conference on March 12th, 2025, showcasing its financial success, market growth, and cost...

Cannara Biotech fera une présentation à la Ventum Canadian Cannabis Conference le 12 mars 2025

Cannara Biotech fera une présentation à la conférence canadienne sur le cannabis Ventum le 12 mars 2025, mettant en valeur son succès financier......

Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025

Mentions: -

Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy

Mentions: -

Cannara Biotech annonce des produits et une part de marché nationale records pour le premier trimestre 2025, ouvrant la voie à un élan continu en 2025

Produits records : Des produits nets de 25,1 millions de dollars au T1 2025, soit une augmentation de 29 % par rapport aux 19,5 millions de dollars du T1...

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Cannara Biotech reported record Q1 2025 revenues of $25.1M, a 29% YoY increase, achieving 4.1% Canadian market share, 15th positive EBITDA quarter...

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Mentions: -

Cannara fait le point sur les documents relatifs à l’assemblée générale annuelle de 2024 dans le contexte de la grève de Postes Canada

MONTRÉAL, 16 déc. 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») (TSXV: LOVE) (OTCQB:...

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

Cannara announces its 2024 AGM will be virtual. Due to a postal strike. Proxy materials are online, and exemptions apply under CSA Blanket Order 51-913...

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

Mentions: -

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Nicholas Sosiak, CFO, will conduct a presentation that will cover key financial and operational results for the fiscal year ended Auguust 31 2024....

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Mentions: -

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability

Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended Aug. 31. The Montreal, Canada-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million). Gross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments. Positive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.

Mentions: LOVE

Cannara Biotech Inc. annonce ses résultats pour le quatrième trimestre et l’exercice 2024 : Augmentation record des ventes et du flux de trésorerie d'exploitation, renforçant sa position de leader sur le marché canadien du cannabis

Total des produits records au quatrième trimestre et pour l’exercice 2024 : 23,4 millions de dollars et 82,2 millions de dollars, soit une augmentation de...

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Cannara Biotech reports record FY2024 revenue of $82.2M (+43%), strong Q4 growth, 3.2% national market share, and plans for expanded production....

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Mentions: -

Cannara Biotech atteint sa part de marché nationale la plus élevée, soit 3,2 %, en juillet 2024 et annonce la tenue d’une webdiffusion pour les investisseurs le 20 août 2024

MONTRÉAL, 16 août 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara » ou la « Société ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), un...

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live...

Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure

Vertically integrated cannabis company Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Tuesday its fiscal third quarter 2024 financial and operating results for the three and nine-month periods ended May 31, 2024. Zohar Krivorot, president and CEO of Cannara, praised the company's "strong performance," during the period, with net revenues reaching CA$19.5 million ($14.2 million) during the quarter, representing a 22.6% year-over-year increase. "Historically, our sales growth has been driven by great customer loyalty and strong demand for our products, amplified by organic word-of-mouth promotion," Krivorot explained. "However, as indicated by our flat quarter-to-quarter results, this can only take us so far. To continue our expansion across the country, we have begun enhancing our sales force and infrastructure."

Mentions: LOVE

Cannara Biotech publie ses résultats financiers pour le troisième trimestre de 2024

Les produits bruts du cannabis avant les taxes d’accise ont augmenté pour atteindre 26,2 millions de dollars au troisième trimestre 2024, contre 20,6...

Cannara Biotech Reports Q3 2024 Financial Results

Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity...

Cannara Biotech Reports Q3 2024 Financial Results

Mentions: -

TSX Venture Exchange, Cannara Biotech Inc., C-Suite at The Open

Cannara Biotech to Webcast Live at VirtualInvestorConferences.com June 30th at 11:30 ET

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

/C O R R E C T I O N -- Cannara Biotech Inc./

Cannara Biotech Enters Into Agreement to Acquire TGOD's State-of-the-art Cultivation and Manufacturing Facility in Valleyfield, Quebec

The Green Organic Dutchman Signs Sale Agreement and Leaseback for its Quebec Facility

Mentions: TGOD.CA

TMX Group Equity Financing Statistics - April 2021

Mentions: X.CA BBIG.CA BITI.CA BTCQ.CA ...

Cannara Virtually Closes The Market